載入中
NASDAQTechnologySoftware - Infrastructure
最新資料
US$11.68
+US$0.27 · +2.37%
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
前收盤價
US$11.68
+US$0.27 · +2.37%
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日內區間
目前US$11.68
52週區間
目前US$11.68
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日內區間
目前US$11.68
52週區間
目前US$11.68
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 12.53萬 USD | 162.38萬 USD | 162.77萬 USD | 150.55萬 USD | 142.07萬 USD |
| 銷貨成本 | 7.26萬 USD | 82.61萬 USD | 60.92萬 USD | 50.51萬 USD | 48.7萬 USD |
| 毛利 | 5.27萬 USD | 79.77萬 USD | 101.85萬 USD | 100.04萬 USD | 93.37萬 USD |
| 研究與開發 | 214.72萬 USD | 2.6萬 USD | 12.23萬 USD | 32.03萬 USD | 31.59萬 USD |
| 銷售、一般及管理費用 | 2633.06萬 USD | 888.61萬 USD | 905.7萬 USD | 1246.96萬 USD | 1170.67萬 USD |
| 營業費用 | 2847.78萬 USD | 1173.72萬 USD | 1313.62萬 USD | 2703.4萬 USD | 2136.23萬 USD |
| 利息支出 | — | — | — | 1065.03萬 USD | — |
| 折舊和攤銷 | 68.86萬 USD | 69.57萬 USD | 73.93萬 USD | 131.31萬 USD | 134.03萬 USD |
| 營業利益 | −2842.52萬 USD | −1093.95萬 USD | −1211.77萬 USD | −2603.37萬 USD | −2042.86萬 USD |
| 淨利 | −2.33億 USD | −1220.13萬 USD | −1398.4萬 USD | −2573.76萬 USD | −1965.72萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2025年9月30日 | 1:15 | — | — |
股票分割 | 2023年4月24日 | 1:20 | — | — |
股票分割 | 2019年10月29日 | 1:10 | — | — |
股票分割 | 2016年10月28日 | 1:25 | — | — |
股票分割 | 2014年10月28日 | 1:75 | — | — |
已生效 2025年9月30日
1:15
已生效 2023年4月24日
1:20
已生效 2019年10月29日
1:10
已生效 2016年10月28日
1:25
已生效 2014年10月28日
1:75
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
